Skip to main content

Table 2 Univariate and multivariate Cox proportion hazard regression analysis for OS

From: Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer

Factors

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Age (≥ 65 vs. < 65)

1.309 (0.679–2.522)

0.421

  

Gender (male vs. female)

1.298 (0.709–2.373)

0.397

  

Tumor location (left colon vs. rectum)

0.586 (0.279–1.233)

0.159

  

Tumor location (right colon vs. rectum)

1.267 (0.625–2.568)

0.511

  

Size (≥ 5 cm vs. < 5cm)

1.300 (0.731–2.310)

0.371

  

Histological type (others vs. adenocarcinoma)

0.733 (0.227–2.364)

0.604

  

Differentiation (poor vs.well/moderate)

1.569 (0.875–2.811)

0.130

  

Lymphovascular invasion (positive vs. negative)

2.006 (1.106–3.637)

0.022

0.865 (0.427–1.751)

0.687

Perineural invasion (positive vs. negative)

2.354 (0.844–6.557)

0.102

  

Harvested LNs

0.960 (0.917–1.003)

0.073

0.945 (0.909–0.992)

0.021

pT category (T4 vs. T1–3)

1.316 (0.732–2.364)

0.358

  

pN category

 N0

Ref.

 

Ref.

 

 N1

3.422 (1.750–6.690)

< 0.001

2.500 (1.179–5.302)

0.017

 N2

3.960 (1.794–8.739)

< 0.001

5.115 (2.236–11.701)

< 0.001

CEA (positive vs. negative)

1.310 (0.738–2.324)

0.355

  

CA199 (positive vs. negative)

0.845 (0.394–1.807)

0.664

  

Cholesterol (high vs. low)

0.947 (0.339–2.639)

0.917

  

Triglyceride (high vs. low)

0.457 (0.180–1.155)

0.098

0.495 (0.176–1.390)

0.181

NLR (high vs. low)

1.730 (0.835–3.578)

0.140

  

CLR (high vs. low)

2.702 (1.500–4.867)

< 0.001

2.142 (1.254–3.659)

0.005

  1. Abbreviations: OS Overall survival, LNs Lymph nodes, CEA Carcinoembryonic antigen, NLR Neutrophil-to-lymphocyte ratio, CLR Cholesterol-to-lymphocyte ratio